Daewoong Co., Ltd. (KRX:003090)
19,980
-170 (-0.84%)
At close: Mar 26, 2025, 3:30 PM KST
Daewoong Revenue
In the year 2024, Daewoong had annual revenue of 1.94T KRW with 6.79% growth. Daewoong had revenue of 503.89B in the quarter ending December 31, 2024, with 12.72% growth.
Revenue
1,936.92B
Revenue Growth
+6.79%
P/S Ratio
0.41
Revenue / Employee
5.44B
Employees
356
Market Cap
785.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,936.92B | 123.08B | 6.79% |
Dec 31, 2023 | 1,813.84B | 116.50B | 6.86% |
Dec 31, 2022 | 1,697.34B | 185.96B | 12.30% |
Dec 31, 2021 | 1,511.37B | 156.04B | 11.51% |
Dec 31, 2020 | 1,355.34B | -10.34B | -0.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |